Schulzer M
Department of Medicine, University of British Columbia, Vancouver, Canada.
Ophthalmology. 1994 Sep;101(9):1589-94; discussion 1595. doi: 10.1016/s0161-6420(94)31133-x.
Despite strictly defined criteria for visual field progression in the ongoing Normal-tension Glaucoma Study, the authors noted a surprisingly large number of patients reaching the endpoint. Traditional methods could not be used to check the diagnostic accuracy of their criteria, because no "gold standard" was established for distinguishing true change from physiologic long-term fluctuation.
The authors developed a statistical method based on the results of duplicate tests for progression in their subjects. This method allowed the authors to assess the sensitivity, specificity, and predictive values of their diagnostic criterion. It also estimated the true incidence of progression and provided standard errors for the estimates.
The authors found that their original strict criteria for progression, based on duplicate testing, produced false calls of progression 57% of the time. By raising the requirement for deterioration and by repeating the entire sequence of duplicate testing once more, the authors have successfully reduced the rate of false calls to 2%.
Accuracy in recognizing progression is improved by not accepting small changes as evidence of progression and by confirming the findings on repeat testing.
尽管在正在进行的正常眼压性青光眼研究中对视神经视野进展有严格定义的标准,但作者注意到达到终点的患者数量惊人地多。由于没有建立用于区分真正变化与生理性长期波动的“金标准”,传统方法无法用于检验其标准的诊断准确性。
作者基于对受试者重复测试的结果开发了一种统计方法。该方法使作者能够评估其诊断标准的敏感性、特异性和预测值。它还估计了进展的真实发生率,并为估计值提供了标准误差。
作者发现,基于重复测试的最初严格的进展标准,有57%的时间会错误判定为进展。通过提高恶化的要求并再次重复整个重复测试序列,作者成功地将错误判定率降低到了2%。
不将微小变化视为进展的证据,并通过重复测试来确认结果,可提高识别进展的准确性。